-
25-02-2015, 07:09 PM
#11521
Another question
Originally Posted by Hancocks
...Attached is the royalties’ prediction from that report....
I notice that the guesses have:
a royalty rate of 1.5% of sales (for all years) in the 2012 one;
a royalty rate of 2.0% of sales (for all years) in the 2013 one and;
a royalty rate of 4.0% of sales (for all years) in the 2014 one.
Can anyone explain that?
Best Wishes
Paper Tiger
-
25-02-2015, 08:06 PM
#11522
Originally Posted by Paper Tiger
I notice that the guesses have:
a royalty rate of 1.5% of sales (for all years) in the 2012 one;
a royalty rate of 2.0% of sales (for all years) in the 2013 one and;
a royalty rate of 4.0% of sales (for all years) in the 2014 one.
Can anyone explain that?
Best Wishes
Paper Tiger
Penalty rates or inflation perhaps.
Its a toughie that one.
-
25-02-2015, 08:55 PM
#11523
Originally Posted by Paper Tiger
I notice that the guesses have:
a royalty rate of 1.5% of sales (for all years) in the 2012 one;
a royalty rate of 2.0% of sales (for all years) in the 2013 one and;
a royalty rate of 4.0% of sales (for all years) in the 2014 one.
Can anyone explain that?
Best Wishes
Paper Tiger
Page 11 of the RM 2014 Report states that royalty rates from CxBladder to be between 2% to 4% based upon industry standards.
-
25-02-2015, 09:06 PM
#11524
A reconciliation perhaps?
Well, trading revenue from external customers for the 6 months to 30 September 2014 was NZD 531k.
Royalties at 4% and an exchange rate of ~.87 results ~AUD$18k payable to CDY
-
25-02-2015, 09:19 PM
#11525
Originally Posted by Balance
Page 11 of the RM 2014 Report states that royalty rates from CxBladder to be between 2% to 4% based upon industry standards.
It says
We change our royalty rate on diagnostic
business from 2% to 4%, in line with the current industry standards.
So it is their estimate that has changed. From 1.5 to 2 now , shall we say 4?
-
25-02-2015, 09:53 PM
#11526
Originally Posted by psychic
It says
We change our royalty rate on diagnostic
business from 2% to 4%, in line with the current industry standards.
So it is their estimate that has changed. From 1.5 to 2 now , shall we say 4?
You are right.
RM Research is very optimistic! They forecast PEB doing sales of 56,981 tests in year to 30 June 2015!
-
25-02-2015, 10:01 PM
#11527
Good thing PEB got those 12 Sales Exec's going recently then eh. Hate to dissappoint the Aussies.
-
25-02-2015, 10:46 PM
#11528
Next pertinent question
Originally Posted by psychic
It says
We change our royalty rate on diagnostic
business from 2% to 4%, in line with the current industry standards.
So it is their estimate that has changed. From 1.5 to 2 now , shall we say 4?
So do PEB have an agreement with CellMid that places a fixed upper limit on royalty rates or are the next 'current industry standards' going to blow out the budget.
Best Wishes
Paper Tiger
ASX:CDY Cellmid == Market Cap:$20M; HY Revenue:$2M; HY Loss:$1M.
-
25-02-2015, 11:22 PM
#11529
Less than 10%
-
26-02-2015, 10:26 AM
#11530
Originally Posted by Hancocks
It may also be worth pondering at this point why RM Research were introduced into the debate.
Most posters will recall that CDY (Cellmid) and RM Research were used as resources to assess PEB prospects when there was little hard research information on PEB?
Guess the lesson to be learnt is that research like Edison or RM Research are as useful as what the companies like to tell the market?
Last edited by Balance; 26-02-2015 at 10:31 AM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks